Navigation Links
Diabetes Alliance to Feature 17 Presentations for Linagliptin and Investigational Compound Empagliflozin^ During the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD)
Date:9/17/2013

roblems to the Boehringer Ingelheim Drug Information Unit by calling 1-800-542-6257.

About Diabetes 
Approximately 25.8 million Americans6 and an estimated 371 million people worldwide have type 1 or type 2 diabetes.3 Type 2 diabetes is the most common type, accounting for an estimated 90 to 95 percent of all diabetes cases.4 Diabetes is a chronic condition that occurs when the body either does not properly produce, or use, the hormone insulin.5 Diabetes was estimated to cost the U.S. $245 billion in 20127.

Boehringer Ingelheim and Eli Lilly and Company 
In January 2011, Boehringer Ingelheim and Eli Lilly and Company announced an alliance in the field of diabetes that centers on three compounds representing several of the largest diabetes treatment classes. This alliance leverages the companies' strengths as two of the world's leading pharmaceutical companies, combining Boehringer Ingelheim's solid track record of research-driven innovation and Lilly's innovative research, experience, and pioneering history in diabetes. By joining forces, the companies demonstrate commitment in the care of patients with diabetes and stand together to focus on patient needs. Find out more about the alliance at www.boehringer-ingelheim.com or www.lilly.com.

About Boehringer Ingelheim 
Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 140 affiliates and more than 46,000 employees. Since it was founded in
'/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
2. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
3. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
4. CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market
5. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
6. Valeritas Inc. Selects dLifes New Diabetes Patient Engagement Solution For Valeritas V-go Disposable Insulin Delivery Device
7. Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe
8. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin to Treat Patients with Type 2 Diabetes
9. JDRF and BD Collaborate to Develop More Accurate and Reliable Glucose Monitoring Devices for People with Type 1 Diabetes
10. Eleven Integrated Health Systems Form Largest Private-Sector Diabetes Registry in United States
11. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 27, 2015 Research and ... the  "North America Portable X Ray Devices Market ...  report to their offering.       (Logo: ... market for Portable X-Ray Devices is ... 2014 to 2020 X-Ray is a ...
(Date:5/27/2015)... , May 27, 2015  With all the daily ... services they provide to keep patients healthy should be ... effect of the Affordable Care Act continues to affect ... payer partners, making it more important than ever that ... with those they contract with for patient care. ...
(Date:5/27/2015)... 26, 2015 Research and Markets( http://www.researchandmarkets.com/research/hxhwtv/asia_pacific ) ... Fluoroscopy Market - Growth, Trends And Forecasts (2014 - ... The Asia Pacific market for ... from 2014 to 2020 Fluoroscopy is the ... images of the interior of the body. The imaging ...
Breaking Medicine Technology:North America Portable X Ray Devices Market Report 2015 - Growth, Trends And Forecasts 2014-2019 2Physicians Seek Payer Inclusion, Not Impediment 2Physicians Seek Payer Inclusion, Not Impediment 3Asia Pacific Fluoroscopy Market Trends and Forecasts 2014 - 2019 2
... Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ), Eli ... Inc. (Nasdaq: ALKS ) today announced that the ... response letter regarding the New Drug Application (NDA) for BYDUREON™ ... complete response letter the FDA requested a thorough QT (tQT) ...
... , Matt Perkins, chief technology officer and senior vice ... provider of ZigBee-based real-time location solutions ( RTLS ) ... real-time location and condition sensing and ZigBee -based ... and beyond at the 2010 Mobile Health Expo.  WHAT: ...
Cached Medicine Technology:Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™ 2Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™ 3Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™ 4Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™ 5Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™ 6Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™ 7Awarepoint to Present 'ZigBee-based Wireless Sensor Networks for Use in Acute Care Hospitals and Beyond' at Mobile Health Expo Speaker Session 2Awarepoint to Present 'ZigBee-based Wireless Sensor Networks for Use in Acute Care Hospitals and Beyond' at Mobile Health Expo Speaker Session 3
(Date:5/27/2015)... Allred Dental located in San Marcos, CA came ... extensive dental treatment - understand the oral issues they are ... problems. , Dr. Jeff Allred calls it “Dental Case Planning” ... of the patient’s oral health and problems together with the ... health problems. , “The dental case planning process starts with ...
(Date:5/27/2015)... New Hampshire (PRWEB) May 27, 2015 ... in the April 2015 issue of the Journal of ... diet sodas and abdominal obesity, Bedford Commons OB-GYN ... water instead of non-nutritive sweetener-flavored beverages. , To ... waist circumference, a comprehensive San Antonio Longitudinal Study of ...
(Date:5/27/2015)... York, NY (PRWEB) May 27, 2015 ... has launched in the U.S. with its first three ... are available for purchase nationwide through http://www.difassusa.com . ... a person’s health and productivity, but some people struggle ... each night. Dormiva™ is a sleep aid designed to ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 This ... current state of the Omega-3 industry. The report ... definitions, classifications, applications and industry chain structure. The ... markets including development trends, competitive landscape analysis, and ... Rieber Oils, Camanchaca Fishing Company, Seadragon Marine Oils, ...
(Date:5/27/2015)... Des Moines, Iowa (PRWEB) May 27, 2015 ... time ticking away, a poll conducted during the "ACA ... 200 webinar poll participants, 75% are currently in the ... a little over 15% were confidently prepared for the ... that was shown during the webinar, those who are ...
Breaking Medicine News(10 mins):Health News:San Marcos Dentistry Office Offering a New Service Dental Case Planning 2Health News:Recent Study About the Link Between Diet Sodas and Abdominal Fat Reinforces Bedford Commons OB-GYN's Recommendation to Drink Plenty of Water 2Health News:Supplement Brand Difass USA Launches in the U.S. with Three Flagship Products Designed to Bring Balance Back to Your Life 2Health News:Omega-3 Market: Global 2015 Analysis & 2020 Forecasts on Market Size 2Health News:Employers are On Track for ACA Reporting According to Businessolver Poll 2
... metabolism in weeks , , MONDAY, April 7 (HealthDay News) ... a person at an increased risk for heart disease ... team of French researchers studying the drug,s effect on ... weeks, the rodents, blood sugar levels rose significantly ...
... the use of robotics for minimally invasive cardiac surgery. ... cardiac surgery. With his arrival, BMC has become one ... the only hospital in Boston, to offer robot-assisted minimally invasive ... artery disease (the most common form of heart disease - ...
... LEANDRO, Calif., April 7, 2008 A,tiny lightstick -- ... of,all fatalities from oral cancer, according to the East ... dental group which,recommends that all adults ask their dentists ... procedure with this product will become,as widespread as the ...
... Nutrition 21,Inc. (Nasdaq: NXXI ), a developer ... sugar levels, improve cardiovascular,health, enhance memory and address chronic ... elected to the Company,s Board of Directors,effective April 7, ... Executive Officer of Iceland,Health, Inc. a company acquired by ...
... matter of molecular To Tell the Truth, as scientists ... from those that are imposters. Powerful gene-scanning technology often ... tissue, making it critical for investigators to winnow out ... the April 8 issue of the journal Cancer Cell, ...
... WOODBURY, N.Y., April 7, 2008 CardWorks Servicing, ... servicer,formerly known as Cardholder Management Services, LLC ("CMS"), ... service the new HumanaAdvance,Visa Card. CardWorks will partner ... to offer the HumanaAdvance Visa. Humana,is one of ...
Cached Medicine News:Health News:Antipsychotic Drug Boosts Risk of Heart Disease, Diabetes 2Health News:Robot-assisted minimally-invasive CABG surgery 2Health News:New ViziLite Plus Could Reduce Oral Cancer Fatalities Predicts East Bay's Creative Dimensions in Dentistry 2Health News:Nutrition 21 Elects Mark H. Stenberg to Board of Directors 2Health News:Data-handling technique finds genes to be team players in curbing brain cancer cell growth 2Health News:Data-handling technique finds genes to be team players in curbing brain cancer cell growth 3Health News:CardWorks Named Servicer of Choice for Innovative Credit Card for Healthcare Services 2Health News:CardWorks Named Servicer of Choice for Innovative Credit Card for Healthcare Services 3
... base with vacuum stage, porous vacuum plate, ... gaskets, lid, instructions. The Model 785 ... or RNA from an agarose gel onto ... only 90 min for transfer, the nucleic ...
... proven electrophoretic transfer apparatus incorporating state-of-the-art plate electrodes ... allows for a very close positioning of the ... power source such as a battery charger, creates ... exceptionally rapid and exact electrophoretic transfer. ...
... GENIE is the proven electrophoretic transfer apparatus incorporating ... uniformity. Its design allows for a very close ... a low voltage power source such as a ... The result is exceptionally rapid and exact electrophoretic ...
... a component of Bio-Rad's modular mini electrophoresis ... high-quality blotting of mini gels. Its modular ... cm gels in just 1 hour. Cooling ... which absorbs heat generated during transfers. The ...
Medicine Products: